SCHEMBL5228212

SCHEMBL5228212

COC(=O)[C@@H](Cc1ccc(N)c(Cl)c1)NC(C)=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 3/20 0.57
LNPEP Q9UIQ6 3/20 0.52
ERAP2 Q6P179 2/20 0.47
LCK P06239 1/20 0.46
ERAP1 Q9NZ08 1/20 0.44
NOS2 P35228 4/20 0.44
HDAC1 Q13547 3/20 0.43
HDAC6 Q9UBN7 3/20 0.43
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC9 Q9UKV0 1/20 0.43
HDAC5 Q9UQL6 1/20 0.43
NOS3 P29474 1/20 0.43
NOS1 P29475 1/20 0.43
CA2 P00918 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4800831 1.00 TACR1 (0.57) TACR1LNPEPERAP2LCKERAP1
SCHEMBL27578169 0.88 TACR1 (0.71) TACR1LCKNOS2HDAC1HDAC6
SCHEMBL4799488 0.86 LMNA (0.52) TACR1CA2
SCHEMBL4799500 0.86 LMNA (0.52) TACR1CA2
SCHEMBL26699643 0.84 KLK5 (0.51) TACR1LNPEPLCK
SCHEMBL26699639 0.84 KLK5 (0.51) TACR1LNPEPLCK
SCHEMBL8238664 0.83 ALDH1A1 (0.51) TACR1LNPEPERAP2ERAP1
SCHEMBL1108337 0.83 TACR1 (0.59) TACR1LNPEPERAP2LCKERAP1
SCHEMBL6501256 0.83 LNPEP (0.51) TACR1LNPEPERAP2LCKERAP1
SCHEMBL6501251 0.83 LNPEP (0.51) TACR1LNPEPERAP2LCKERAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1737842-A1 SELECTED CGRP ANTAGONISTS, METHOD FOR PRODUCING THE SAME AND THE USE THEREOF AS DRUGS Boehringer Ingelheim International GmbH (DE) 2007-01-03 EP disclosed
WO-2005100343-A1 SELECTED CGRP ANTAGONISTS, METHOD FOR PRODUCING THE SAME AND THE USE THEREOF AS DRUGS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-10-27 WO disclosed